3351 |
English |
Closing Cases and Assigning Treatment Outcomes |
Published on LMS |
Link |
Dr. Priyadarshini |
Abhimanyu |
6 months |
3351 |
Marathi |
Closing Cases and Assigning Treatment Outcomes |
|
|
Dr. Priyadarshini |
Abhimanyu |
6 months |
3351 |
Telugu |
Closing Cases and Assigning Treatment Outcomes |
|
|
Dr. Priyadarshini |
Abhimanyu |
6 months |
3352 |
English |
Reinitiating case |
Published on LMS |
Link |
Shahnawaz |
Abhimanyu |
6 months |
3352 |
Marathi |
Reinitiating case |
|
|
Shahnawaz |
Abhimanyu |
6 months |
3352 |
Telugu |
Reinitiating case |
|
|
Shahnawaz |
Abhimanyu |
6 months |
3354 |
English |
Transferring a patient |
Published on LMS |
Link |
Shahnawaz |
Abhimanyu |
6 months |
3354 |
Marathi |
Transferring a patient |
|
|
Shahnawaz |
Abhimanyu |
6 months |
3354 |
Telugu |
Transferring a patient |
|
|
Shahnawaz |
Abhimanyu |
6 months |
596 |
English |
Drug-Sensitive Tuberculosis [DS-TB] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
596 |
Gujarati |
Drug-Sensitive Tuberculosis [DS-TB] |
Under Development |
|
Archana.Singh |
Abhimanyu |
6 months |
596 |
Hindi |
Drug-Sensitive Tuberculosis(DS-TB) |
Approved |
|
Archana.Singh |
Abhimanyu |
6 months |
596 |
Marathi |
Drug-Sensitive Tuberculosis(DS-TB) |
|
|
Archana.Singh |
Abhimanyu |
6 months |
596 |
Tamil |
Drug-Sensitive Tuberculosis(DS-TB) |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
596 |
Telugu |
Drug-Sensitive Tuberculosis(DS-TB) |
Approved |
Link |
Archana.Singh |
Abhimanyu |
6 months |
623 |
English |
TB Treatment – Steps |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
623 |
Gujarati |
TB Treatment – Steps |
Under Development |
Link |
Awele |
Abhimanyu |
6 months |
623 |
Marathi |
DS-TB Treatment – Patient Flow |
Final Review |
Link |
Awele |
Abhimanyu |
6 months |
623 |
Telugu |
DS-TB Treatment – Patient Flow |
Final Review |
Link |
Awele |
Abhimanyu |
6 months |
770 |
English |
Treatment Regimen for DSTB – Adult |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
770 |
Gujarati |
Treatment Regimen for DSTB – Adult |
Under Development |
|
Awele |
Abhimanyu |
6 months |
770 |
Hindi |
Treatment Regimen for DSTB – Adult |
Approved |
|
Awele |
Abhimanyu |
6 months |
770 |
Marathi |
Treatment Regimen for DSTB – Adult |
Published on LMS |
|
Awele |
Abhimanyu |
6 months |
770 |
Tamil |
Treatment Regimen for DSTB – Adult |
Approved |
Link |
Awele |
Abhimanyu |
6 months |
770 |
Telugu |
Treatment Regimen for DSTB – Adult |
Approved |
Link |
Awele |
Abhimanyu |
6 months |
768 |
English |
Treatment Regimen for DSTB - Pediatrics |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
768 |
Gujarati |
Treatment Regimen for DSTB - Pediatrics |
Under Development |
Link |
Awele |
Abhimanyu |
6 months |
768 |
Marathi |
Treatment Regimen for DSTB - Pediatrics |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
768 |
Telugu |
Treatment Regimen for DSTB - Pediatrics |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
627 |
English |
ADRs to First Line Treatment |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
627 |
Gujarati |
ADRs to First Line Treatment |
Under Development |
|
Archana.Singh |
Abhimanyu |
6 months |
627 |
Hindi |
Adverse Drug Reactions(ADRs) to First Line Treatment |
Approved |
|
Archana.Singh |
Abhimanyu |
6 months |
627 |
Marathi |
Adverse Drug Reactions(ADRs) to First Line Treatment |
|
|
Archana.Singh |
Abhimanyu |
6 months |
627 |
Tamil |
Adverse Drug Reactions(ADRs) to First Line Treatment |
Approved |
Link |
Archana.Singh |
Abhimanyu |
6 months |
627 |
Telugu |
Adverse Drug Reactions(ADRs) to First Line Treatment |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
633 |
English |
DR-TB Treatment Regimens |
Depreciated |
Link |
Awele |
Abhimanyu |
6 months |
633 |
Gujarati |
DR-TB Treatment Regimens |
Depreciated |
Link |
Awele |
Abhimanyu |
6 months |
1131 |
English |
Pre-treatment Counselling |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
1157 |
English |
Interim Treatment Outcomes of DR-TB Cases |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
1786 |
English |
Final Treatment Outcomes of DR-TB Cases |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
1886 |
English |
Follow-up Monitoring of DR-TB Patients |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
5738 |
English |
Follow up sputum examination for DR-TB |
Published on LMS |
Link |
SwathiK |
SwathiK |
6 months |
1147 |
English |
Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
5770 |
English |
Eligibility Criteria for H Mono/poly DR-TB Regimen |
Depreciated |
Link |
SwathiK |
SwathiK |
6 months |
1148 |
English |
Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
1149 |
English |
Replacement Sequence in the H Mono/Poly DR-TB |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
5766 |
English |
Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
SwathiK |
SwathiK |
6 months |
1129 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |
1029 |
English |
Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment |
Published on LMS |
Link |
Awele |
Abhimanyu |
6 months |
1134 |
English |
Shorter oral Bedaquiline-containing MDR/RR-TB regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
6 months |